-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Anterix, Raises Price Target to $133

Benzinga·07/20/2026 14:28:52
Listen to the news
JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $50 to $133.